Deadly Deception: Delhi Police Bust ₹10 Crore Fake-Drug Racket Targeting Cancer and Liver Patients

NEW DELHI — In a major crackdown on a syndicate preying on the most vulnerable, the Delhi Police has dismantled a sophisticated four-member criminal enterprise allegedly manufacturing and distributing counterfeit medicines intended for the treatment of cancer, chronic liver disease, and other life-threatening illnesses.

The operation, which functioned under the deceptive brand name “Unitel Pharma,” was neutralized following a series of coordinated raids across the National Capital Region (NCR). Authorities seized a staggering haul of spurious medications and high-end manufacturing equipment valued at approximately ₹10 crore ($1.2 million USD). The arrests highlight a burgeoning crisis in the pharmaceutical supply chain, where counterfeiters are increasingly targeting high-cost, high-stakes therapies, leaving patients at risk of treatment failure or sudden toxicity.

The Anatomy of the Bust

The syndicate, reportedly led by Manoj Kumar Mishra, a native of Manipur, operated a clandestine manufacturing unit that churned out thousands of fake capsules and tablets. Unlike traditional “me-too” generics—which are legal but cheaper versions of off-patent drugs—these products were outright counterfeits designed to mimic expensive, branded oncology and hepatology medications.

Key Evidence Recovered:

• Seized Stock: Over 90,000 counterfeit capsules and an assortment of pills.

• Machinery: Heavy-duty industrial-grade manufacturing and packaging equipment used to create professional-looking strips and bottles.

• Documentation: Financial ledgers suggesting the operation had already funneled crores of rupees through the illicit sale of these products across multiple Indian states.

Investigating officers are currently tracing the distribution network to determine how many hospitals, small-scale pharmacies, or online aggregators may have unknowingly (or knowingly) stocked these lethal imitations.

Why Counterfeit Specialty Drugs are a “Death Sentence”

For a patient battling Stage IV cancer or advanced cirrhosis, the precision of their medication is the only thing standing between remission and relapse. Modern specialty drugs, such as kinase inhibitors or targeted biologics, are engineered to interact with specific molecular pathways.

When these drugs are faked, they typically contain one of three things: no active ingredient, an incorrect dosage, or toxic fillers like starch, chalk, or industrial dyes.

“The clinical implications are catastrophic,” says Dr. Anjali Sharma, a senior oncologist and clinical trials researcher who has observed the fallout of such rackets. “In cancer care, the price gap between a genuine branded pill and a cheap starch-filled copy can be tens of lakhs per course. This massive profit margin is exactly what attracts these syndicates. For the patient, taking a fake pill is effectively the same as stopping treatment entirely, allowing the disease to progress unchecked.”

In chronic liver disease, the danger is doubled. Because the liver is responsible for detoxifying the body, any contaminants or “unpredictable toxic loads” in a spurious drug can cause acute-on-chronic liver failure, leading to rapid death in an already compromised patient.

A Systemic Pattern of Exploitation

This ₹10-crore seizure is not a “one-off” event but part of a disturbing trend in the Delhi-NCR region. Over the last three years, multiple rackets have been uncovered, including one in 2024 where a police chargesheet confirmed that at least one patient died after receiving a spurious cancer injection.

Dr. Rakesh Khanna, a prominent hepatologist and public health advocate, argues that the problem is rooted in a fragmented regulatory framework. “In India, the penalties for selling spurious medicines are often treated as minor criminal or civil offenses,” Dr. Khanna explains. “Until these acts are prosecuted as ‘crimes against life’—essentially attempted murder—the financial incentives will continue to outweigh the legal risks.”

Statistics from the Central Drugs Standard Control Organisation (CDSCO) and recent enforcement drives suggest that Delhi has become a central node for these illicit supply chains due to its concentration of premier oncology centers and its role as a logistics hub for North India.

Protecting Yourself: A Guide for Patients and Caregivers

As authorities work to scrub the supply chain of “Unitel Pharma” products, healthcare professionals urge patients to remain vigilant. The following red flags and safety protocols are essential for anyone purchasing high-cost specialty medications:

1. Source Verification

• Stick to Hospital Pharmacies: Purchase critical medications only from licensed pharmacies physically attached to or officially recommended by major reputable hospitals.

• Avoid “Too Good To Be True” Pricing: If a vendor offers a 50% to 90% discount on a drug that is globally price-controlled, it is almost certainly counterfeit or illegally diverted.

2. Physical Inspection

• Packaging Integrity: Check for holographic seals, batch numbers, and expiry dates. Counterfeit packaging often has subtle spelling errors or blurred logos.

• The “Cash-Only” Trap: Be wary of vendors who insist on cash transactions without a GST-compliant invoice. A legitimate bill is your only paper trail for safety.

3. Verification Tools

Many pharmaceutical companies now use SURE (Scannable Unique Real-time Evidence) or QR codes on packaging. Always scan these codes using the manufacturer’s official app to verify the batch.

The Road Ahead: Policy and Regulation

Public health experts are calling for a multi-pronged approach to prevent future rackets:

• Real-time Track-and-Trace: Implementing blockchain-based tracking for every vial of high-value medicine from the factory to the patient.

• Stricter Penalties: Amending the Drugs and Cosmetics Act to ensure non-bailable warrants and life imprisonment for those manufacturing fake life-saving drugs.

• Expanded Testing: Increasing the frequency of random sample collection from distributors located near major medical hubs.

While the Delhi Police’s latest bust has undoubtedly saved lives by removing 90,000 fake doses from the street, the “Unitel Pharma” case serves as a grim reminder. In the world of high-stakes medicine, the difference between a cure and a catastrophe can sometimes be as thin as the foil on a pill strip.

Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.

References

1. News Report: Delhi Police dismantle ₹10-crore counterfeit medicine syndicate; four arrested. (NDTV, May 6, 2026).